2023 update on Italian guidelines for the treatment of type 2 diabetes

Affiliations

¹ Diabetology, Azienda Ospedaliero-Universitaria Careggi, Careggi Hospital, University of Florence, Via Delle Oblate 4, 50141, Florence, Italy. edoardo.mannucci@unifi.it.
² Diabetology, ASUI, Trieste, Italy.
³ FAND, Milan, and FederDiabete Lazio, Rome, Italy.
⁴ Endocrinology and Metabolic Diseases, Hospital of Alessandria, Alessandria, Italy.
⁵ Endocrinology and Metabolic Diseases, Gemelli Hospital, Catholic University of Rome, Rome, Italy.
⁶ University of Florence, Florence, Italy.
⁷ San Martino Hospital, Genoa, Italy.
⁸ Società Italiana di Medicina Generale (SIMG), Florence, Italy.
⁹ Niguarda Ca' Granda Hospital, Milan, Italy.
¹⁰ Endocrinology, Diabetology and Metabolic Diseases, University of Verona, Verona, Italy.
¹¹ Laboratory of Clinical Pedagogy, University of Turin, Turin, Italy.
¹² Scuola Superiore S. Anna, Pisa, Italy.
¹³ Diabetology, Azienda Ospedaliero-Universitaria Careggi, Careggi Hospital, University of Florence, Via Delle Oblate 4, 50141, Florence, Italy.

Edoardo Mannucci et al. Acta Diabetol. 2023 Aug.

. 2023 Aug;60(8):1119-1151.

doi: 10.1007/s00592-023-02107-x. Epub 2023 May 26.

¹ Diabetology, Azienda Ospedaliero-Universitaria Careggi, Careggi Hospital, University of Florence, Via Delle Oblate 4, 50141, Florence, Italy. edoardo.mannucci@unifi.it.
² Diabetology, ASUI, Trieste, Italy.
³ FAND, Milan, and FederDiabete Lazio, Rome, Italy.
⁴ Endocrinology and Metabolic Diseases, Hospital of Alessandria, Alessandria, Italy.
⁵ Endocrinology and Metabolic Diseases, Gemelli Hospital, Catholic University of Rome, Rome, Italy.
⁶ University of Florence, Florence, Italy.
⁷ San Martino Hospital, Genoa, Italy.
⁸ Società Italiana di Medicina Generale (SIMG), Florence, Italy.
⁹ Niguarda Ca' Granda Hospital, Milan, Italy.
¹⁰ Endocrinology, Diabetology and Metabolic Diseases, University of Verona, Verona, Italy.
¹¹ Laboratory of Clinical Pedagogy, University of Turin, Turin, Italy.
¹² Scuola Superiore S. Anna, Pisa, Italy.
¹³ Diabetology, Azienda Ospedaliero-Universitaria Careggi, Careggi Hospital, University of Florence, Via Delle Oblate 4, 50141, Florence, Italy.

No abstract available

Figures

1. Mannucci E, Candido R, Delle Monache L, et al. Italian guidelines for the treatment of type 2 diabetes (in Eng) Nutr Metab Cardiovasc Dis: NMCD. 2022 doi: 10.1016/j.numecd.2022.01.027. - DOI - PubMed
1. Mannucci E, Candido R, Monache LD, et al. Italian guidelines for the treatment of type 2 diabetes (in Eng) Acta Diabetol. 2022 doi: 10.1007/s00592-022-01857-4. - DOI - PMC - PubMed
1. Jabbour SA, Frías JP, Ahmed A, et al. Efficacy and safety over 2 years of exenatide plus dapagliflozin in the DURATION-8 study: a multicenter, double-blind, phase 3, randomized controlled trial (in Eng) Diabetes Care. 2020;43(10):2528–2536. doi: 10.2337/dc19-1350. - DOI - PMC - PubMed
1. Møller G, Andersen HK, Snorgaard O. A systematic review and meta-analysis of nutrition therapy compared with dietary advice in patients with type 2 diabetes (in Eng) Am J Clin Nutr. 2017;106(6):1394–1400. doi: 10.3945/ajcn.116.139626. - DOI - PubMed
1. Silverii GA, Botarelli L, Dicembrini I, et al. Low-carbohydrate diets and type 2 diabetes treatment: a meta-analysis of randomized controlled trials (in Eng) Acta Diabetol. 2020;57(11):1375–1382. doi: 10.1007/s00592-020-01568-8. - DOI - PubMed